Episode 92: The Landscape of COVID-19 Testing

In this episode, we talk to Levana Sani, co-founder and CEO of Nalagenetics, a meditech company based in Indonesia and Singapore that focuses on genetic testing for drug responses, but has now partially shifted focus to helping set up labs for COVID-19 testing. We dive into the basics of genetic testing, in particular human genotyping, which is what Nalagenetics as a company does in order to help doctors develop personalized medicine for their patients, tailored to their specific genetic profile. We talk to Levi about how her company has pivoted from genetic testing to COVID-19 testing, in particular qPCR (quantitative polymerase chain reaction) testing and comparing this particular method to the more widely known rapid testing method, which has had its critics. We also discuss how Nalagenetics have helped private companies — specifically huge corporations that employ thousands of people — test their workforce and keep their community safe, which goes into the conversation about private and public sector responses to COVID-19 and the democratization of testing. We discuss the ethics behind testing when there are limited test kits and how we can ensure the accessibility of testing to those who really need it.

You can listen to Episode 92: The Landscape of COVID-19 Testing online on Radio and Podcast. Open the player on this page to stream the available audio.

Episode 92: The Landscape of COVID-19 Testing is an episode from Dialogika Podcast by Dialogika Podcast.

This episode is 00:37:04 long.

This episode was published on May 27, 2020.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Dialogika Podcast when more episodes are available from the podcast feed.